CRT 2025

Late-Breaking Clinical Science Coronary II

Late-Breaking Clinical Science | Coronary II

Late Breaker Moderator(s)

• 

  David J. Cohen, MD, FSCAI

  Director of Clinical and Outcomes Research
  Cardiovascular Research Foundation
  New York, New York, United States

  Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)
• 

  Goran Stankovic, MD, PhD

  Head, Department of cardiology
  University Clinical Center of Serbia
  Belgrade, Serbia

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Terumo: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

Panelist(s)

• 

  Usman Baber, MD, MS

  Professor of Medicine
  University of Oklahoma Health Sciences Center
  Oklahoma City, Oklahoma, United States

  Disclosure information not submitted.
• 

  Neal S. Kleiman, MD, FACC, MSCAI

  Medical Director, Cardiac Catheterization Laboratories
  Houston Methodist DeBakey Heart and Vascular Center
  Houston, Texas, United States

  Disclosure information not submitted.
• 

  Ian C. Gilchrist, Sr., MD, MSCAI

  Professor Of Medicine
  Penn State University/Hershey Medical Center
  Hummelstown, Pennsylvania, United States

  Disclosure(s): No financial relationships to disclose
• 

  Stephen G. Ellis, MD, FACC, FSCAI

  Director of Interventional Cardiology, Senior Academic Officer
  Cleveland Clinic
  Beachwood, Ohio, United States

  Disclosure(s): No financial relationships to disclose
• 

  On Topaz, FACC, FSCAI,FACP

  Professor of Medicine ,Duke University School of Medicine.
  Duke University School of Medici
  Biltmore Lake, North Carolina, United States

  Disclosure(s): No financial relationships to disclose
• 

  Ji Young Park, MD, PhD

  Professor
  Nowon Eulji Medical Center, Eulji University
  Seoul, Seoul-t'ukpyolsi, Republic of Korea

  Disclosure(s): No financial relationships to disclose
• 

  Valeria Paradies, MD, MSc

  Interventional Cardiologist
  Maasstad Hospital, Rotterdam, The Netherlands
  Rotterdam, Netherlands

  Disclosure information not submitted.
• 

  Azeem Latib, MD

  Director, Interventional Cardiology & Structural Heart Interventions
  Montefiore Medical Center
  Scarsdale, New York, United States

  Disclosure(s): Boston Scientific, Metronic: Consulting Fees (e.g., advisory boards) (Ongoing)